InspireMD Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 71.9% | 71.3% | 80.7% | 81.0% | 77.1% | 75.9% | 80.9% | 82.4% | 65.8% | 62.5% | 79.8% | 143.7% | 81.9% | |
| 28.1% | 28.7% | 19.3% | 19.0% | 22.9% | 24.1% | 19.1% | 17.6% | 34.2% | 37.5% | 20.2% | -43.7% | 18.1% | |
| 135.6% | 115.6% | 173.7% | 195.6% | 216.3% | 189.5% | 265.5% | 215.6% | 144.1% | 110.4% | 140.2% | 242.5% | 149.1% | |
| 198.7% | 168.6% | 254.4% | 215.4% | 192.8% | 216.9% | 323.3% | 299.6% | 233.4% | 144.5% | 139.0% | 234.6% | 178.2% | |
| 390.6% | 358.5% | 510.0% | 494.0% | 490.4% | 504.7% | 768.6% | 749.8% | 551.5% | 421.2% | 431.6% | 771.9% | 512.1% | |
| -362.4% | -329.8% | -490.7% | -475.0% | -467.5% | -480.6% | -749.5% | -732.2% | -517.3% | -383.7% | -411.4% | -815.6% | -494.0% | |
| – | 7.1% | – | – | – | – | – | 7.4% | – | – | – | – | – | |
| -332.8% | -303.2% | -465.4% | -454.8% | -435.9% | -467.7% | -730.3% | -739.7% | -503.7% | -371.5% | 8.5% | -808.8% | -354.6% | |
| -3.7% | 3.7% | 1.7% | – | – | 3.0% | – | – | – | 2.0% | – | – | – | |
| -332.8% | -306.9% | -465.4% | -454.8% | -435.9% | -470.7% | -730.3% | -739.7% | -503.7% | -373.5% | 8.5% | -808.8% | -355.2% | |
| -329.0% | -299.8% | -460.8% | -451.0% | -432.0% | -463.8% | -723.9% | -726.2% | -499.4% | -366.9% | 12.9% | -799.9% | -349.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.